This is the authors' abstract. We don't add key points for this paper.
Tumor Lysis syndrome is an oncologic emergency with high morbidity and mortality. Recognition of the constellation of hyperuricemia, hyperphosphatemia, hyperkalemia, and hypocalcemia is critical to identifying the disease in time to intervene. Failure to treat can lead to permanent kidney failure, arrhythmias, seizures, and death. Metastatic melanoma as an impetus for tumor lysis syndrome is extremely rare. Acute liver failure secondary to metastatic melanoma is another rare presentation of metastatic melanoma. A lack of obvious metastases on imaging and the insidious spread of melanoma makes this a dangerous combination with few good treatment options. A 74-year-old male was admitted with worsening fatigue and jaundice. He was found to be in renal and hepatic failure and to have laboratory findings concerning for tumor lysis syndrome despite not having a known malignancy. Further workup demonstrated metastatic melanoma from what the patient characterized as “a birth mark.” The patient's condition rapidly deteriorated and he was placed on comfort care. He died four days after presentation to the Emergency Department. Why should an emergency physician be aware of this? Tumor Lysis Syndrome is a life-threatening oncologic emergency and one that is typically associated with known hematologic malignancy. This assumption may limit the ability of the clinician to identify the nature of the emergency.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Cochran-Caggiano et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: